Epidemiological characteristics of leukemia in China, 2005–2017: a log-linear regression and age-period-cohort analysis

Author:

Lin Kangqian,Jia Huaimiao,Cao Miao,Xu Tongtong,Chen Zuhai,Song Xi,Miao Yingfang,Yao Teng,Dong Chenxian,Shao Jianjiang,Guo Heng,Hu Yunhua,Yan YizhongORCID

Abstract

Abstract Background Leukemia is a threat to human health, and there are relatively few studies on the incidence, mortality and disease burden analysis of leukemia in China. This study aimed to analyze the incidence and mortality rates of leukemia in China from 2005 to 2017 and estimate their age-period-cohort effects, it is an important prerequisite for effective prevention and control of leukemia. Methods Leukemia incidence and mortality data from 2005 to 2017 were collected from the Chinese Cancer Registry Annual Report. Joinpoint regression model was used to estimate the average annual percentage change (AAPC) and annual percentage change (APC) response time trend. Age-period-cohort model was constructed to analyze the effects of age, period and cohort. Results The age-standardized incidence rate of leukemia was 4.54/100,000 from 2005 to 2017, showed an increasing trend with AAPC of 1.9% (95% CI: 1.3%, 2.5%). The age-standardized mortality rate was 2.91/100,000, showed an increasing trend from 2005 to 2012 with APC of 2.1% (95%CI: 0.4%, 3.9%) and then a decreasing trend from 2012 to 2017 with APC of -2.5% (95%CI: -5.3%, 0.3%). The age-standardized incidence (mortality) rates of leukemia were not only higher in males than that in females, but also increased more rapidly. The incidence of leukemia in rural areas was lower than in urban areas, but the AAPC was 2.2 times higher than urban areas. Children aged 0–4 years were at higher risk of leukemia. The risk of leukemia incidence and mortality increased with age. The period effect of leukemia mortality risk showed a decreasing trend, while the cohort effect showed an increasing and then decreasing trend with the turning point of 1955–1959. Conclusions The age-standardized incidence rate of leukemia in China showed an increasing trend from 2005 to 2017, while the age-standardized mortality rate increased first and then decreased in 2012 as a turning point. Differences existed by gender and region. The risk of leukemia incidence and mortality increased accordingly with age. The risk of mortality due to leukemia gradually decreased from 2005 to 2017. Leukemia remains a public health problem that requires continuous attention.

Funder

The Shihezi University High-level Talents Program

The Shihezi University self-funded project

The Shihezi University College students’ innovation and entrepreneurship training program

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Reference68 articles.

1. Zongchao L, Zhexuan L, Yang Z, Tong Z, Jingying Z, Weicheng Y, et al. Interpretation on the report of Global Cancer Statistics 2020. J Multidisciplinary Cancer Manage (Electronic Version). 2021a;7:1–14.

2. WHO. Global health estimates: Leading causes of death. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death, 2020(accessed 2023-3-10).

3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

4. Yantao T, Wenzhe K. New progress in research on global cancer incidence. China Med. 2021;16:1446–7.

5. Jing Y, Hai-hong J, Huan L, Ge L, Yong-yi B, Na-na L, et al. Trends and risk factors of leukemia disease burden in China, 1990–2019. J Public Health Prev Med. 2022;33:23–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3